Glucagonomas: Aggressive Pancreatic Tumors with Unique Features
Author Information
Author(s): Mattiolo Paola, Bevere Michele, Mafficini Andrea, Verschuur Anna Vera D., Calicchia Martina, Hackeng Wenzel M., Simbolo Michele, Paiella Salvatore, Dreijerink Koen M. A., Landoni Luca, Pedron Serena, Cingarlini Sara, Salvia Roberto, Milella Michele, Lawlor Rita T., Valk Gerlof D., Vriens Menno R., Scarpa Aldo
Primary Institution: University of Verona
Hypothesis
This study aims to define the histomorphology, alpha- and beta-cell differentiation, and molecular features of glucagon-producing pancreatic neuroendocrine tumors.
Conclusion
Pancreatic glucagonomas are distinct tumors with specific clinical symptoms and aggressive characteristics, enriched in certain genetic mutations.
Supporting Evidence
- All tumors were well-differentiated G1 tumors, except one case that was G2.
- All neoplasms showed classic histomorphology with solid-trabecular and nested architecture.
- Frequent lymphatic and vascular invasion was observed in all cases.
- NGS revealed recurrent somatic MEN1 and ATRX/DAXX mutations.
- One case exhibited a high tumor mutational burden of 41.0 mut/Mb.
Takeaway
Glucagonomas are rare tumors in the pancreas that can cause serious symptoms and have unique genetic features that make them aggressive.
Methodology
The study involved immunohistochemistry, fluorescent in situ hybridization, and next-generation sequencing on six identified cases of glucagonomas.
Limitations
The sample size was small, and whole-genome sequencing was not performed, which may have missed some genetic drivers.
Participant Demographics
Four male and two female patients with a mean age of 62.5 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website